Day

November 13, 2019
BioXyTran, Inc. — Tissue Regeneration for Life Bioxytran Inc. (OTC: BIXT) is a late stage biotechnology company that is developing a first-in-class oxygen treatment platform for victims of brain stroke trauma. The company’s lead drug candidate, BXT-25, is getting ready to proceed to testing.  BXT-25 has many properties of an existing, well tested drug, called...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases